• Home
  • Company Profile
  • News
  • Products
  • Cart
  • Checkout
  • My Account
  • Terms & Conditions
  • Privacy Policy
Paragon BioTeck, Inc.Paragon BioTeck, Inc.
  • HOME
  • ABOUT
    • Company Profile
    • Business Integrity
  • PRODUCTS
    • Diagnostics
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% 15 mL
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% 10mL
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 10% 5mL
  • NEWS
  • CONTACT

Study: Occlusion Therapy May Reduce Dry Eye in Contact Lens Wearers

Home » News » Study: Occlusion Therapy May Reduce Dry Eye in Contact Lens Wearers

Study: Occlusion Therapy May Reduce Dry Eye in Contact Lens Wearers

07/22/2016 Punctal Occlusion

Over 30 million Americans wear contact lenses (“Contact Lenses:  Fast Facts”), but many are unaware of the relationship between contacts and dry eye disease.

 

Dry eye disease can present as a wide range of symptoms, including feelings of dryness, grittiness, irritation, or simply tired eyes. Many people assume that they have to stop wearing contacts in order to experience relief from these symptoms.

 

However, a recent study conducted by Marc R. Bloomenstein, OD, FAAO, has found that use of punctum plugs may reduce symptoms associated with dry eye disease in contact lens wearers.

 

Punctal occlusion therapy involves the insertion of a tiny, biocompatible device into a patient’s lacrimal tear duct, which blocks the drainage of tears from the eye. Occlusion therapy may be a useful alternative for contact lens wearers who have tried using eye drops and other therapies but failed to find sufficient relief.

 

The patients in Dr. Bloomenstein’s study not only experienced less contact lens discomfort throughout the day, but also benefited from increased sharpness of vision. Remarkably, “At the conclusion of the study…90 percent of [patients] chose to undergo additional punctal occlusion.”

 

As Dr. Karpecki, OD, FAAO, states in the video below, “Contact lens wearers that begin to show early signs of dry eye disease tend to be an ideal candidate for occlusion therapy.”

 

 

Paragon BioTeck, Inc., has developed a line of absorbable and non-absorbable punctum plugs to provide occlusion therapy for the treatment of symptoms associated with dry eye disease, which may result from allergies, cataracts, or contact lens intolerance. Patients who are unsure whether occlusion therapy is right for them should talk with their eye doctor.

 

Dry eye symptoms are the leading reason why people choose to stop wearing contact lenses (Heiting 2015), but punctum plugs may be a valid remedial option that can provide both temporary and long-term relief.   

 

Paul Karpecki, OD, FAAO, is a nationally recognized leader and pioneer in dry eye disease and Clinician at the OSD Center at Gaddie Eye Centers in Louisville, Kentucky.

 

Citations:

  1. “Contact Lenses: Fast Facts.” Centers for Disease Control and Prevention.” January 22, 2015.
  2. Bloomstein, Marc R., OD, FAAO. “http://optometrytimes.modernmedicine.com/optometrytimes/content/tags/contact-lens/punctal-occlusion-may-improve-visual-acuity-contact-lens-paPunctal occlusion may improve visual acuity for contact lens patients.” Optometry Times. July 1, 2014
  3. Heiting, Garym OD. “Contact Lenses for Dry Eyes.” All About Vision. May 2015.
Share
0

You also might be interested in

Paragon BioTeck, Inc. Announces Call for 2018 Koch Kellan Scholarship Applicants

Oct 2, 2017

The Koch Kellan Scholarship honors a graduate medical student pursuing[...]

Xinxin Zhang shares her experience at ASCRS•ASOS

Jun 12, 2017

2017 Koch Kellan Scholar, Xinxin Zhang, was formally presented with her scholarship award at a ceremony held on Sunday, May 7. Ms. Zhang was invited to attend the 2017 ASCRS•ASOS annual meeting in Los Angeles on behalf of Paragon BioTeck where she had the opportunity to explore the conference and meet ophthalmic industry leaders. Read on to hear her thoughts about the conference and ceremony.

5 Questions: 2017 Koch Kellan Scholar Xinxin Zhang

May 23, 2017

Each year, Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to a third-year ophthalmology student. The scholarship, named for two pillars of the eye care industry — Paul Koch, MD, and Robert Kellan, MD — highlights rising stars who share our dedication to underserved medical needs. This year, we are proud to introduce our 2017 Koch Kellan Scholar: Xinxin Zhang. We caught up with her after the announcement to learn more about her exciting work and future plans.

RECENT POSTS

  • Paragon BioTeck Reformulated FRESHKOTE®, Prompting Eyevance Acquisition 09/14/2018
  • Paragon BioTeck, Inc. Hosts Pearl Buck Preschool Holiday Event 12/01/2017
  • Paragon BioTeck, Inc. Announces Call for 2018 Koch Kellan Scholarship Applicants 10/02/2017
  • Talking to Patients About Eye Health 08/24/2017
  • Xinxin Zhang shares her experience at ASCRS•ASOS 06/12/2017

Newsletter Sign-Up

  • This field is for validation purposes and should be left unchanged.

HOME

Contact Us
News

PRODUCTS

Diagnostics

ABOUT

Company Profile
Business Integrity

CUSTOMER SERVICE

1-888-424-1192
customercare@paragonbioteck.com

© 2017 Paragon BioTeck, Inc. All Rights Reserved.

Privacy Policy | Return Policy | Terms of Use | Social Media Guidelines


Prev Next